BridgeMD
New treatment option for Pancreatitis
Official title Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis
ClinicalTrials.gov ID: NCT07330284
What this study is testing
- What it's testing
- This study is designed to learn whether rinsing the papilla with cold water at the end of an ERCP procedure, in addition to standard medicine, can help lower the chance of developing pancreatitis, which is the most common major complication after ERCP.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Native papilla present.
- Undergoing ERCP for diagnostic or therapeutic indications.
- Able to provide informed consent.
You likely can't join if
- Post-operative reconstructed intestinal tract other than Billroth I reconstruction.
- Acute pancreatitis at the time of ERCP.
- Chronic pancreatitis.
- Pancreatic head cancer with occlusion of the main pancreatic duct.
- Existing pancreatic duct stent or need for prophylactic pancreatic duct stenting during the index ERCP.
- Known contraindications or allergy to indomethacin or other NSAIDs.
See the full eligibility criteria
- Native papilla present.
- Undergoing ERCP for diagnostic or therapeutic indications.
- Able to provide informed consent.
- Post-operative reconstructed intestinal tract other than Billroth I reconstruction.
- Acute pancreatitis at the time of ERCP.
- Chronic pancreatitis.
- Pancreatic head cancer with occlusion of the main pancreatic duct.
- Existing pancreatic duct stent or need for prophylactic pancreatic duct stenting during the index ERCP.
- Known contraindications or allergy to indomethacin or other NSAIDs.
- Significant renal impairment (eGFR \< 30 mL/min/1.73m²).
- Active peptic ulcer disease or history of NSAID-induced gastrointestinal bleeding.
The study team makes the final eligibility decision.
Where it's taking place
- Kansas City, Kansas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kansas City, Kansas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.